Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name DGCR5
   Synonyms DGCR5, LINC00037, NCRNA00037
   Region GRCh38_22:18970514-18994628    Sequence
   Ensembl ENSG00000237517
   RefSeq NR_002733
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name non small cell lung cancer
   ICD-0-3 C34  M8046/3
   Methods qPCR, Western blot, Luciferase reporter assay etc.
   Sample cell lines (A549, H460, H1299 and HEK-293T)
   Expression Pattern up-regulated
   Function Description

DGCR5 was up-regulated in the enriched CSCs of NSCLC. DGCR5 can inhibit the stemness of NSLCL while overexpression of DGCR5 promoted CSC-like traits.In addition, miR-330-5p was predicted as target of DGCR.Meanwhile,miR-330-5p was decreased in CSCs of NSCLC.miR-330-5p mimics repressed the stemness while miR-330-5p inhibition enhanced CSC-like properties by targeting CD44.Taken these together,DGCR5 can act as a crucial regulator of CSCs in NSCLC by modulating miR-330-5p/CD44 axis.

   Pubmed ID 29663359
   Year 2018
   Title LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
   External Links
   Links for  DGCR5 GenBank       HGNC       lncrnadb       Noncode
   Links for  non small cell lung cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.